William Lis - 13 Apr 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
13 Apr 2023
Net transactions value
-$12,240
Form type
4
Filing time
14 Apr 2023, 16:14:22 UTC
Previous filing
07 Mar 2023
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Sale $12,240 -8,500 -12% $1.44 61,486 13 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the Reporting Person solely in order to satisfy certain tax obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.